Millennium Management
VERA icon

Millennium Management’s Vera Therapeutics VERA Stock Holding History

Millennium Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
278,658
-14,839
-5% -$553K ﹤0.01% 2105
2026
Q1 		$11.8M Buy
293,497
+93,774
+47% +$4.04M ﹤0.01% 2016
2025
Q4 		$10.1M Sell
199,723
-398,731
-67% -$14.2M ﹤0.01% 2253
2025
Q3 		$17.4M Buy
598,454
+379,623
+173% +$8.78M 0.01% 1810
2025
Q2 		$5.16M Buy
218,831
+83,937
+62% +$1.89M ﹤0.01% 2960
2025
Q1 		$3.24M Buy
134,894
+57,246
+74% +$1.84M ﹤0.01% 3311
2024
Q4 		$3.28M Sell
77,648
-218,787
-74% -$9.69M ﹤0.01% 3209
2024
Q3 		$13.1M Buy
296,435
+263,038
+788% +$9.98M 0.01% 1949
2024
Q2 		$1.21M Sell
33,397
-1,394
-4% -$55.3K ﹤0.01% 3966
2024
Q1 		$1.5M Buy
+34,791
New +$1.24M ﹤0.01% 3976
2023
Q3 		– Sell
-333,689
Closed -$5.36M – 6603
2023
Q2 		$5.36M Sell
333,689
-1,553,662
-82% -$14M ﹤0.01% 2620
2023
Q1 		$14.6M Buy
1,887,351
+778,702
+70% +$6.01M 0.01% 1602
2022
Q4 		$21.5M Buy
1,108,649
+711,721
+179% +$12.9M 0.01% 1381
2022
Q3 		$8.46M Buy
396,928
+120,685
+44% +$2.26M 0.01% 2353
2022
Q2 		$3.76M Buy
276,243
+142,743
+107% +$2.49M ﹤0.01% 3087
2022
Q1 		$3.14M Buy
+133,500
New +$2.87M ﹤0.01% 3450
2021
Q3 		– Sell
-81,452
Closed -$1.08M – 7282
2021
Q2 		$1.08M Buy
+81,452
New +$1.27M ﹤0.01% 4592

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management's VERA Position: Q2 2026 in Review

Millennium Management reduced its Vera Therapeutics (VERA) stake by 5.1% in Q2 2026, selling an estimated $553K and leaving 278,658 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Millennium Management first reported a position in VERA in Q2 2021 and has held it in 17 quarters since. The position peaked at $21.5M in Q4 2022. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Millennium Management held 278,658 shares of Vera Therapeutics worth $12M as of Q2 2026.
  • Millennium Management sold 14,839 Vera Therapeutics shares in Q2 2026, an estimated $553K.
  • Vera Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2105 holding.
  • Millennium Management first reported a position in Vera Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Millennium Management's Vera Therapeutics position peaked at $21.5M in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.